1. Home
  2. EVI vs CRBP Comparison

EVI vs CRBP Comparison

Compare EVI & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EVI Industries Inc.

EVI

EVI Industries Inc.

HOLD

Current Price

$15.22

Market Cap

204.6M

ML Signal

HOLD

CRBP

Corbus Pharmaceuticals Holdings Inc.

HOLD

Current Price

$8.86

Market Cap

190.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVI
CRBP
Founded
1959
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
204.6M
190.3M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
EVI
CRBP
Price
$15.22
$8.86
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
$35.00
$45.50
AVG Volume (30 Days)
80.0K
577.7K
Earning Date
05-15-2026
05-08-2026
Dividend Yield
1.81%
N/A
EPS Growth
N/A
N/A
EPS
0.48
N/A
Revenue
$389,830,000.00
$4,822,272.00
Revenue This Year
$15.53
N/A
Revenue Next Year
$3.83
$116.00
P/E Ratio
$30.23
N/A
Revenue Growth
10.26
97.62
52 Week Low
$12.75
$7.12
52 Week High
$34.82
$20.56

Technical Indicators

Market Signals
Indicator
EVI
CRBP
Relative Strength Index (RSI) 56.90 36.08
Support Level $13.87 $7.62
Resistance Level $17.46 $9.66
Average True Range (ATR) 0.94 0.70
MACD 0.04 -0.16
Stochastic Oscillator 79.57 5.66

Price Performance

Historical Comparison
EVI
CRBP

About EVI EVI Industries Inc.

EVI Industries Inc is a value-added distributor and service provider in the commercial laundry industry. It sells and leases commercial laundry equipment, specializing in washing, drying, finishing, material handling, water heating, power generation, and water reuse applications. The company supports its equipment offerings with installation, maintenance, and repair services through a large network of trained technicians. It serves a wide range of customers, including commercial, industrial, institutional, government, and retail sectors. Geographically, the company serves various countries including United States, Canada, the Caribbean, and Latin America.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: